年度報告ANNUAL REPORTSihuan Pharmaceutical Holdings Group Ltd.四環醫藥控股集團有限公司(incorporated in Bermuda with limited liability)（於百慕達註冊成立之有限公司）Stock Code 股份代號：0460 Gen PDF一定要壓細10M內公司簡介CORPORATE PROFILEFounded in 2001 and listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2010, Sihuan Pharmaceutical Holdings Group Ltd. (“Sihuan Pharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) (Stock Code: 00460.HK) is an international medical aesthetic and biopharmaceutical company led and driven by innovation, with a leading independent production, and research and development (“R&D”) technology platform, a rich global product pipeline and a mature and excellent sales system. Focusing on high-growth therapeutic areas such as medical aesthetics, oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine and industrial hemp, it adheres to its overall strategic objective of “Adhering to the full-speed promotion of a two-wheeled strategy of Sihuan medical aesthetics and biopharmaceuticals” to build a leading medical aesthetics and biopharmaceutical enterprise in China.四環醫藥控股集團有限公司（「四環醫藥」或「本公司」，連同其附屬公司為「本集團」）（股份代號：00460.HK）創立於二零零一年，二零一零年於香港聯合交易所有限公司主板上市，是一家以創新為引領，堅持創新驅動，擁有獨立領先的自主生產、研究與開發（「研發」）技術平台，具備豐富的全球化產品管線和成熟卓越銷售體系的國際化醫美及生物製藥企業。四環醫藥聚焦醫美、腫瘤、代謝、糖尿病、心腦血管、現代中藥及工業大麻等高增長治療領域，一直秉承「堅持全速推進四環醫美及生物製藥雙輪驅動戰略」的整體戰略目標來打造中國領先的醫美及生物製藥企業。 Gen PDF一定要壓細10M內2公司資料Corporate Information4發展里程Milestones16獎項Awards23財務摘要Financial Summary24主席報告Chairman’s Statement28管理層討論及分析Management Discussion and Analysis71董事履歷Biographical Details of Directors76企業管治報告Corporate Governance Report102董事會報告Report of Directors126獨立核數師報告Independent Auditor’s Report133綜合損益及其他全面收益表Consolidated Statement of Profit or Loss and Other Comprehensive Income135綜合財務狀況表Consolidated Statement of Financial Position137綜合權益變動表Consolidated Statement of Changes in Equity139綜合現金流量表Consolidated Statement of Cash Flows141財務報表附註Notes to the Financial Statements目錄CONTENTS 公司資料CORPORATE INFORMATION四環醫藥控股集團有限公司 SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.2Gen PDF一定要壓細10M內BOARD OF DIRECTORS (THE “BOARD”)Executive DirectorsDr. Che Fengsheng (Chairman)Dr. Guo Weicheng (Deputy Chairman and Chief Executive Officer (“CEO”)) Dr. Zhang JionglongMs. Miao Guili (Deputy CEO and Chief Financial Officer (“CFO“)) Ms. Chen YanlingIndependent Non-executive DirectorsMr. Tsang Wah Kwong Dr. Zhu XunMr. Wang Guan (appointed on 1 April 2023) Mr. Patrick Sun (resigned on 1 April 2023)JOINT COMPANY SECRETARIESMs. Chen Yanling Mr. Li Kin WaiAUTHORISED REPRESENTATIVESMs. Chen Yanling Mr. Li Kin WaiAUDIT COMMITTEEMr. Tsang Wah Kwong (Chairman) (appointed as chairman on 1 April 2023)Dr. Zhu XunMr. Wang Guan (appointed on 1 April 2023) Mr. Patrick Sun (resigned on 1 April 2023)REMUNERATION COMMITTEEDr. Zhu Xun (Chairman) Dr. Che FengshengMr. Tsang Wah KwongMr. Wang Guan (appointed on 1 April 2023) Mr. Patrick Sun (resigned on 1 April 2023)NOMINATION COMMITTEEMr. Wang Guan (Chairman) (appointed on 1 April 2023)Dr. Guo WeichengMr. Tsang Wah Kwong (ceased to be chairman on 1 April 2023) Dr. Zhu XunMr. Patrick Sun (resigned on 1 April 2023)董事會（「董事會」）執行董事車馮升醫生（主席）郭維城醫生（副主席兼行政總裁）張炯龍醫生繆瑰麗女士（副行政總裁兼首席財務官）陳燕玲女士獨立非執行董事曾華光先生朱迅博士王冠先生（於二零二三年四月一日獲委任）辛定華先生（於二零二三年四月一日辭任）聯席公司秘書陳燕玲女士李健威先生授權代表陳燕玲女士李健威先生審核委員會曾華光先生（主席） （於二零二三年四月一日獲委任為主席）朱迅博士王冠先生（於二零二三年四月一日獲委任）辛定華先生 （於二零二三年四月一日辭任）薪酬委員會朱迅博士（主席）車馮升醫生曾華光先生王冠先生（於二零二三年四月一日獲委任）辛定華先生（於二零二三年四月一日辭任）提名委員會王冠先生（主席） （於二零二三年四月一日獲委任）郭維城醫生曾華光先生 （於二零二三年四月一日不再擔任主席）朱迅博士辛定華先生（於二零二三年四月一日辭任） 公司資料CORPORATE INFORMATION年度報告 ANNUAL REPORT 20233Gen PDF一定要壓細10M內RISK MANAGEMENT COMMITTEEMs. Chen Yanling (Co-chairman) (appointed as co-chairman on 1 April 2023) Ms. Miao Guili (Co-chairman) (appointed as co-chairman on 1 April 2023) Dr. Guo WeichengMr. Tsang Wah KwongMr. Patrick Sun (resigned on 1 April 2023)INDEPENDENT AUDITORErnst & YoungCertified Public Accountants and Registered Public Interest Entity Auditor27/F, One Taikoo Place 979 King’s Road Quarry Bay, Hong KongREGISTERED OFFICEClarendon House 2 Church StreetHamilton HM 11 BermudaPRINCIPAL PLACE OF BUSINESS IN HONG KONGRoom 4905, Office Tower, Convention Plaza 1 Harbour RoadWanchai, Hong KongPRINCIPAL SHARE REGISTRARConyers Corporate Services (Bermuda) Limited Clarendon House2 Church StreetHamilton HM 11 BermudaHONG KONG BRANCH SHARE REGISTRARTricor Investor Services Limited 17/F, Far East Finance Centre 16 Harcourt Road, Hong KongWEBSITEwww.sihuanpharm.comSTOCK CODE0460風險管理委員會陳燕玲女士（聯席主席） （於二零二三年四月一日獲委任為聯席主席）繆瑰麗女士（聯席主席） （於二零二三年四月一日獲委任為聯席主席）郭維城醫生曾華光先生辛定華先生（於二零二三年四月一日辭任）獨立核數師安永會計師事務所執業會計師及註冊公眾利益實體核數師香港鰂魚涌英皇道979號太古坊一座27樓註冊辦事處Clarendon House 2 Church StreetHamilton HM 11 Bermuda香港主要營業地點香港灣仔港灣道1號會展廣場辦公大樓4905室主要股份過戶登記處Conyers Corporate Services (Bermuda) Limited Clarendon House2 Church StreetHamilton HM 11 Bermuda香港股份過戶登記分處卓佳證券登記有限公司香港夏愨道16號遠東金融中心17樓網址www.sihuanpharm.com股份代號0460 發展